α-glucosidase and glycation inhibitory effects of costus speciosus leaves

Handunge Kumudu Irani Perera1, Walgama Kankanamlage Vindhya Kalpani Premadasa2,3, Jeyakumaran Poongunran4,5

  • 1Department of Biochemistry, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. kumudup@pdn.ac.lk.

Abstract

Insights

Costus speciosus (COS) leaves show significant potential in managing hyperglycemia by inhibiting alpha-glucosidase and reducing protein glycation. These findings support its use for hypoglycemic effects and preventing diabetes complications.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Phytomedicine

Background:

  • Hyperglycemia in diabetes elevates protein glycation, leading to long-term complications.
  • Controlling postprandial blood glucose spikes is a key strategy in diabetes management.
  • Costus speciosus (COS) is explored for its potential hypoglycemic and anti-glycation properties.

Purpose of the Study:

  • To evaluate the in vitro inhibitory effects of COS leaves on key enzymes involved in glucose metabolism.
  • To assess the impact of COS on protein glycation and related processes.
  • To provide scientific evidence for the traditional use of COS in managing diabetes.

Main Methods:

  • Methanol extracts of COS leaves were used to test inhibitory effects on porcine pancreatic alpha-amylase and Saccharomyces cerevisiae alpha-glucosidase.
  • In vitro assays measured inhibition of fructosamine formation and glycation-induced protein cross-linking using bovine serum albumin and chicken egg lysozyme.
  • Nitroblue tetrazolium and polyacrylamide gel electrophoresis were employed to quantify glycation markers.

Main Results:

  • COS leaves exhibited significant alpha-glucosidase inhibitory activity (IC50 = 67.5 μg/ml), outperforming Acarbose.
  • Alpha-amylase inhibition by COS was less potent (IC50 = 5.88 mg/ml) compared to Acarbose.
  • COS demonstrated notable inhibition of fructosamine formation and protein cross-linking, comparable to aminoguanidine.

Conclusions:

  • Methanol extracts of COS leaves possess significant in vitro inhibitory activity against alpha-glucosidase.
  • COS effectively reduces fructosamine formation and inhibits glycation-induced protein cross-linking.
  • These results support the hypoglycemic potential of COS leaves and their role in mitigating diabetes-related protein damage.

Related Concept Videos

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
848
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.0K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
933